PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $3.63 billion. The enterprise value is $3.66 billion.
Important Dates
The next confirmed earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 54.11 million shares outstanding. The number of shares has increased by 12.07% in one year.
| Current Share Class | 54.11M |
| Shares Outstanding | 54.11M |
| Shares Change (YoY) | +12.07% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 2.61% |
| Owned by Institutions (%) | 87.69% |
| Float | 51.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.91 |
| Forward PS | 12.82 |
| PB Ratio | 15.08 |
| P/TBV Ratio | 15.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.02, with a Debt / Equity ratio of 0.34.
| Current Ratio | 6.02 |
| Quick Ratio | 4.95 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.53 |
Financial Efficiency
Return on equity (ROE) is -37.02% and return on invested capital (ROIC) is -18.88%.
| Return on Equity (ROE) | -37.02% |
| Return on Assets (ROA) | -16.73% |
| Return on Invested Capital (ROIC) | -18.88% |
| Return on Capital Employed (ROCE) | -33.22% |
| Revenue Per Employee | $319,238 |
| Profits Per Employee | -$159,842 |
| Employee Count | 626 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.67% in the last 52 weeks. The beta is 1.02, so PRCT's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +39.67% |
| 50-Day Moving Average | 82.55 |
| 200-Day Moving Average | 74.49 |
| Relative Strength Index (RSI) | 36.23 |
| Average Volume (20 Days) | 943,185 |
Short Selling Information
The latest short interest is 7.07 million, so 13.07% of the outstanding shares have been sold short.
| Short Interest | 7.07M |
| Short Previous Month | 6.89M |
| Short % of Shares Out | 13.07% |
| Short % of Float | 13.63% |
| Short Ratio (days to cover) | 11.83 |
Income Statement
In the last 12 months, PRCT had revenue of $199.84 million and -$100.06 million in losses. Loss per share was -$1.95.
| Revenue | 199.84M |
| Gross Profit | 114.68M |
| Operating Income | -106.46M |
| Pretax Income | -103.71M |
| Net Income | -100.06M |
| EBITDA | -101.36M |
| EBIT | -106.46M |
| Loss Per Share | -$1.95 |
Full Income StatementBalance Sheet
The company has $196.76 million in cash and $82.64 million in debt, giving a net cash position of $114.12 million or $2.11 per share.
| Cash & Cash Equivalents | 196.76M |
| Total Debt | 82.64M |
| Net Cash | 114.12M |
| Net Cash Per Share | $2.11 |
| Equity (Book Value) | 241.22M |
| Book Value Per Share | 4.63 |
| Working Capital | 269.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$91.62 million and capital expenditures -$11.95 million, giving a free cash flow of -$103.57 million.
| Operating Cash Flow | -91.62M |
| Capital Expenditures | -11.95M |
| Free Cash Flow | -103.57M |
| FCF Per Share | -$1.91 |
Full Cash Flow StatementMargins
Gross margin is 57.39%, with operating and profit margins of -53.27% and -50.07%.
| Gross Margin | 57.39% |
| Operating Margin | -53.27% |
| Pretax Margin | -50.07% |
| Profit Margin | -50.07% |
| EBITDA Margin | -50.72% |
| EBIT Margin | -53.27% |
| FCF Margin | n/a |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.07% |
| Shareholder Yield | -12.07% |
| Earnings Yield | -2.65% |
| FCF Yield | -2.74% |
Dividend DetailsAnalyst Forecast
The average price target for PRCT is $97.86, which is 45.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $97.86 |
| Price Target Difference | 45.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 31.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 10.77 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.77 |
| Piotroski F-Score | 4 |